AdvertisementAdvertise with NZME.
Latest fromCompanies
The Dow: Known by all, used by few
One of the great disconnects of the financial world involves our best-known stock market indicator - the Dow industrials.
Ambrose Evans-Pritchard: Indebted firms about to get their fingers burnt
Sitting on the desks of central bank governors and regulators across the world is a scholarly report that gently hints at horrors in store.
Fran O'Sullivan: 'Fonterra first' puts rest outside the loop
Wellington Beltway denizens often refer to MFAT as standing for the Ministry for Fonterra and other Trade.
Fonterra aims for baby milk boost
A partnership with Beingmate Baby & Child could begin boosting Fonterra's branded infant formula sales in China this year.
Fletcher Building drives index higher
New Zealand shares rose yesterday, paced by Fletcher Building, as investors were drawn to firms that have under-performed the benchmark index.
Kiwis need to think big: Indian tycoon
Indian billionaire Nandan Nilekani says scale is a problem New Zealand companies need to overcome to crack the growing Indian market.
Fonterra's $750m China deal
Dairy giant Fonterra will purchase an 18.8 per cent stake in Chinese infant formula maker Beingmate Baby & Child, slightly less than the 20 per cent shareholding it was aiming for.
Oil giants trade to profit from slump
Known for their oil fields, refineries, and petrol stations, BP, Royal Dutch Shell and Total are also the world's biggest oil traders.
Christopher Adams: All eyes on reaction of Chinese media and consumers
After everything New Zealand's infant formula industry has been through over the past few years, the last thing it needed was yesterday's news of the 1080 threat.
Formula 1080 threat sends dollar down
The New Zealand dollar dropped by half a US cent on news of a threat to contaminate infant and other formula with 1080 poison.
SBS mortgage sign of rates rivalry
Competition is continuing to heat up in the mortgage market, with a new rate dipping below 5 per cent.
Baby formula: Mums on warpath
Six complaints have been made to the Commerce Commission since its preliminary decision to allow infant formula companies to restrict their advertising.